Skip to main content

Table 2 Anthropometric measurements and change in pubertal status in follow-up, a comparison of the groups

From: The effects of the covid-19 pandemic on puberty: a cross-sectional, multicenter study from Turkey

 

Group 1 (n:60)

Group 2 (n: 21)

Group 3 (n:18)

 

Visit 1-before pandemic

Visit 2-before pandemic

Visit 1-before pandemic

Visit 2-pandemic

Visit 1-pandemic

Visit 2-pandemic

Chronological age (yr)

8.4

8.8

8.1

8.6

7.63*

7.9

Duration between the two visits (yr)

-

0.45

-

0.46

-

0.34

BMI SDS

0.67

0.59

0.24

0.48

0.29

0.13

Height SDS

0.71

0.8

0.89

1.2

0.98

0.87

Delta BMI-SDS (median)

-

-0.02

-

0.21

-

-0.06

Delta height SDS (median)

-

0.14

-

0.24

-

0.08

Tanner stage (%)

 T II

61.7

41.7

71.4

38.1

66.7

27.8

 T III

31.7

33.3

14.3

33.3

22.2

55.6

 T IV

5

10

4.8

9.5

11.1

11.1

 T V

1.7

5

4.8

4.8

0

0

Change in pubertal stage during follow-up

No change (%)

-

67%

-

57%

-

61%

 + 1 stage (%)

-

32%

-

38%

-

39%

 + 2 stages (%)

-

1%

-

5%

-

0

GnRH analogue therapy in follow-up n (%)

-

5(8)§

-

4(20)

-

8(44)

Basal LH (median) (IU/L)

0.1

-

0.17

-

0.25

-

Peak LH at LHRH stimulation test (IU/L)

5

-

8.2

-

5.6

-

Basal estradiol (median)(pg/ml)

19.5

-

16

-

21.5

-

Uterine length (mm)

35.5

-

32.5

-

38

-

Ovarian volume (cm3)

3

-

2.6

-

2.5

-

Screen time (h/day)

-

-

1.5

3

2.1

3.25

  1. *p:0.013 (group 3 vs groups 1&2),p:0.005 (group 3 vs groups 1&2),p:0.04 (group 2 vs groups 1&3),
  2. §p:0.003 (group 1 vs groups 2&3